CST is a private, family-owned company, founded by scientists and dedicated to providing high-quality research tools.

Joined March 2009
3,270 Photos and videos
CST Principal Scientist Alissa Nelson, PhD, shows how combining antibody-based assays with DIA LC‑MS and PTMScan® ubiquitin profiling can fully characterize an androgen receptor degrader—from on‑target activity to off‑target substrates and site‑level ubiquitination changes.
1
145
Unlock spatial insights into complex tumor biology. Join us at Visiopharm’s Research Rebellion Tour to learn how mIHC assays interrogate spatial context across cell types and biomarkers within the TME. 👤 Sarah Klein, PhD (CST) 🗓 June 24 | 10 AM ET
1
240
If it’s a CST antibody, you can trust it’s been put to the test—and proven ready for publication-worthy science. Learn why CST has more recombinant antibodies on the CiteAb Top 100 list than any other vendor: hubs.ly/Q03-Q9r50
68
🔄🔬How do some tumors bounce back with new, therapy‑resistant identities? 👉 Learn how dedifferentiation, blocked differentiation, and transdifferentiation reshape tumor cell fate, and find biomarkers and antibody tools to study Phenotypic Plasticity. hubs.ly/Q04g81M_0
48
Streamline CAR Cell Detection for Analytical QC 🔵 Detect any G4S linker-containing CAR-T cell with one reagent 🔵 Simplify in-process QC and lot release assays 🔵 PE-conjugated antibodies plug into your existing analytical QC workflows
1
173
Studying the hallmark of Evading Growth Suppressors is key to uncovering how tumor suppressor inactivation removes the brakes for uncontrolled cellular proliferation 🚫 Learn more: hubs.ly/Q042y6T30
52
Studying genomic instability? Gain a functional readout of homologous recombination repair in FFPE tissue with the new IHC-validated Rad51 (F4L4Y) Rabbit Monoclonal Antibody #84555 to detect Rad51 foci. See the data for yourself. hubs.ly/Q04g8LCR0
97
CST is celebrating #PrideMonth alongside all the members of our Pride Signaling Employee Resource Group We support a welcoming culture for our LGBTQ employees and allies by providing programs that promote representation, increase awareness, and address barriers to inclusion
78
🔬Mapping phenotypic plasticity in your tumor models? Tap an expert‑curated shortlist of markers for EMT, blocked differentiation, and transdifferentiation—all in one place. 🧰 Find key pathway diagrams and antibody tools to build your research toolbox. hubs.ly/Q04g89gf0
52
Last chance to register for our antibody validation webinar on June 2, 2026, 1:00–2:00 PM EDT. Learn what’s at stake with poorly validated antibodies and how CST validates each new antibody as a scientific project. 👉 Register now: hubs.ly/Q04fR4KZ0
42
Reveal cellular dynamics within native tissue context the faster and easier way. Get reliable insights at scale on the platform you use with rigorously validated multiplex spatial solutions from CST. 🔍 Learn more: hubs.ly/Q046xdxL0
39
• Enrich any G4S linker-containing CAR-T cells • Biotin-conjugated antibodies are amenable to magnetic bead-based CAR-T cell enrichment on cell therapy manufacturing instruments • Standardize percent CAR cells and mitigate issues associated with low transduction efficiencies
1
1
1
119
When cell division should stop, how does proliferation remain active in cancer cells? 🚦 Learn more about proliferative signaling via IHC- and WB-validated antibodies against key readouts in the Akt/PI3K/mTOR and RAS-RAF-MEK-ERK pathways: hubs.ly/Q042lKp_0
67
Chimeric antibodies from CST. The same antibody clones you know and trust, now available in mouse, horse, and feline hosts to support your multiplex IF experiments. Also in 20 µL trial sizes! ⬇️ hubs.ly/Q04gjWvZ0
68
🚫🧪 Triton X-100 is now banned in the EU—but still ingrained in many lab workflows. See how CST scientists validated a greener, high‑performing alternative without sacrificing staining quality or reproducibility. ♻️ Read the full story on the #CSTBlog. hubs.ly/Q04d488P0
54
🧶🧬 Why are epigenetic changes such powerful cancer “switches”—and how can some be reversed? 👉 Learn how nonmutational epigenetic reprogramming fuels EMT and cell survival, and explore key biomarkers, pathway diagrams, and antibody tools on the #CSTBlog hubs.ly/Q04g8ddn0
52